Review



luciferase 2 luc2  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    ATCC luciferase 2 luc2
    Luciferase 2 Luc2, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 39 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc2+luciferase/pmc13049841-35-15-18?v=ATCC
    Average 94 stars, based on 39 article reviews
    luciferase 2 luc2 - by Bioz Stars, 2026-07
    94/100 stars

    Images



    Similar Products

    94
    ATCC luciferase 2 luc2
    Luciferase 2 Luc2, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc2+luciferase/pmc13049841-35-15-18?v=ATCC
    Average 94 stars, based on 1 article reviews
    luciferase 2 luc2 - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    Addgene inc plasmid puas luciferase
    Plasmid Puas Luciferase, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc2+luciferase/pmc12915196-38-0-3?v=Addgene+inc
    Average 94 stars, based on 1 article reviews
    plasmid puas luciferase - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    90
    ATCC luciferase reporter gene
    Luciferase Reporter Gene, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc2+luciferase/pmc12998182-26-30-34?v=ATCC
    Average 90 stars, based on 1 article reviews
    luciferase reporter gene - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    94
    ATCC luciferase labeled raji cells
    (A) CAR expression in activated human T cells 24-hours after treatment with unconjugated LNP–CAR mRNA or aCD7/tLNP-CAR mRNA at doses of 0.01, 0.1, or 1 μg mRNA per million cells. (B and C) Quantification of CAR expression in CD4⁺ and CD8⁺ T cells treated with unconjugated LNP-CAR mRNA. (D and E) Quantification of CAR expression in CD4⁺ and CD8⁺ T cells treated with aCD7/tLNP-CAR mRNA. (F) Experimental scheme for evaluating the cytolytic activity of CAR T cells against target cells. (G) Representative images showing Cytotox Green fluorescence indicating <t>Raji</t> cell death in co-cultures with T cells treated with unmodified LNP-CAR or aCD7/tLNP-CAR at effector-to-target (E: T) ratios of 1:1, 2:1, 5:1, and 10:1. (H) Quantification of Cytotox Green fluorescence shown in (G). (I) Quantification of Raji cell viability in co-culture based on luciferase activity. n = 2 biological replicates. Data are shown as mean ± SD. Scale bar = 100 μm.
    Luciferase Labeled Raji Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc2+luciferase/bio_rxiv__64898__2026__01__23__701374-90-12-15?v=ATCC
    Average 94 stars, based on 1 article reviews
    luciferase labeled raji cells - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    93
    Addgene inc tdtomato luciferase
    (A) CAR expression in activated human T cells 24-hours after treatment with unconjugated LNP–CAR mRNA or aCD7/tLNP-CAR mRNA at doses of 0.01, 0.1, or 1 μg mRNA per million cells. (B and C) Quantification of CAR expression in CD4⁺ and CD8⁺ T cells treated with unconjugated LNP-CAR mRNA. (D and E) Quantification of CAR expression in CD4⁺ and CD8⁺ T cells treated with aCD7/tLNP-CAR mRNA. (F) Experimental scheme for evaluating the cytolytic activity of CAR T cells against target cells. (G) Representative images showing Cytotox Green fluorescence indicating <t>Raji</t> cell death in co-cultures with T cells treated with unmodified LNP-CAR or aCD7/tLNP-CAR at effector-to-target (E: T) ratios of 1:1, 2:1, 5:1, and 10:1. (H) Quantification of Cytotox Green fluorescence shown in (G). (I) Quantification of Raji cell viability in co-culture based on luciferase activity. n = 2 biological replicates. Data are shown as mean ± SD. Scale bar = 100 μm.
    Tdtomato Luciferase, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc2+luciferase/bio_rxiv__64898__2026__01__22__701120-189-7-8?v=Addgene+inc
    Average 93 stars, based on 1 article reviews
    tdtomato luciferase - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    Addgene inc gfp luciferase construct
    (A) CAR expression in activated human T cells 24-hours after treatment with unconjugated LNP–CAR mRNA or aCD7/tLNP-CAR mRNA at doses of 0.01, 0.1, or 1 μg mRNA per million cells. (B and C) Quantification of CAR expression in CD4⁺ and CD8⁺ T cells treated with unconjugated LNP-CAR mRNA. (D and E) Quantification of CAR expression in CD4⁺ and CD8⁺ T cells treated with aCD7/tLNP-CAR mRNA. (F) Experimental scheme for evaluating the cytolytic activity of CAR T cells against target cells. (G) Representative images showing Cytotox Green fluorescence indicating <t>Raji</t> cell death in co-cultures with T cells treated with unmodified LNP-CAR or aCD7/tLNP-CAR at effector-to-target (E: T) ratios of 1:1, 2:1, 5:1, and 10:1. (H) Quantification of Cytotox Green fluorescence shown in (G). (I) Quantification of Raji cell viability in co-culture based on luciferase activity. n = 2 biological replicates. Data are shown as mean ± SD. Scale bar = 100 μm.
    Gfp Luciferase Construct, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc2+luciferase/pmc12851450-179-15-18?v=Addgene+inc
    Average 93 stars, based on 1 article reviews
    gfp luciferase construct - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    94
    Addgene inc uas luciferase vector
    (A) CAR expression in activated human T cells 24-hours after treatment with unconjugated LNP–CAR mRNA or aCD7/tLNP-CAR mRNA at doses of 0.01, 0.1, or 1 μg mRNA per million cells. (B and C) Quantification of CAR expression in CD4⁺ and CD8⁺ T cells treated with unconjugated LNP-CAR mRNA. (D and E) Quantification of CAR expression in CD4⁺ and CD8⁺ T cells treated with aCD7/tLNP-CAR mRNA. (F) Experimental scheme for evaluating the cytolytic activity of CAR T cells against target cells. (G) Representative images showing Cytotox Green fluorescence indicating <t>Raji</t> cell death in co-cultures with T cells treated with unmodified LNP-CAR or aCD7/tLNP-CAR at effector-to-target (E: T) ratios of 1:1, 2:1, 5:1, and 10:1. (H) Quantification of Cytotox Green fluorescence shown in (G). (I) Quantification of Raji cell viability in co-culture based on luciferase activity. n = 2 biological replicates. Data are shown as mean ± SD. Scale bar = 100 μm.
    Uas Luciferase Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/luc2+luciferase/pm41534572-45-3-8?v=Addgene+inc
    Average 94 stars, based on 1 article reviews
    uas luciferase vector - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    Image Search Results


    (A) CAR expression in activated human T cells 24-hours after treatment with unconjugated LNP–CAR mRNA or aCD7/tLNP-CAR mRNA at doses of 0.01, 0.1, or 1 μg mRNA per million cells. (B and C) Quantification of CAR expression in CD4⁺ and CD8⁺ T cells treated with unconjugated LNP-CAR mRNA. (D and E) Quantification of CAR expression in CD4⁺ and CD8⁺ T cells treated with aCD7/tLNP-CAR mRNA. (F) Experimental scheme for evaluating the cytolytic activity of CAR T cells against target cells. (G) Representative images showing Cytotox Green fluorescence indicating Raji cell death in co-cultures with T cells treated with unmodified LNP-CAR or aCD7/tLNP-CAR at effector-to-target (E: T) ratios of 1:1, 2:1, 5:1, and 10:1. (H) Quantification of Cytotox Green fluorescence shown in (G). (I) Quantification of Raji cell viability in co-culture based on luciferase activity. n = 2 biological replicates. Data are shown as mean ± SD. Scale bar = 100 μm.

    Journal: bioRxiv

    Article Title: Rapid receptor internalization potentiates CD7-targeted lipid nanoparticles for efficient mRNA delivery to T cells and in vivo CAR T-cell engineering

    doi: 10.64898/2026.01.23.701374

    Figure Lengend Snippet: (A) CAR expression in activated human T cells 24-hours after treatment with unconjugated LNP–CAR mRNA or aCD7/tLNP-CAR mRNA at doses of 0.01, 0.1, or 1 μg mRNA per million cells. (B and C) Quantification of CAR expression in CD4⁺ and CD8⁺ T cells treated with unconjugated LNP-CAR mRNA. (D and E) Quantification of CAR expression in CD4⁺ and CD8⁺ T cells treated with aCD7/tLNP-CAR mRNA. (F) Experimental scheme for evaluating the cytolytic activity of CAR T cells against target cells. (G) Representative images showing Cytotox Green fluorescence indicating Raji cell death in co-cultures with T cells treated with unmodified LNP-CAR or aCD7/tLNP-CAR at effector-to-target (E: T) ratios of 1:1, 2:1, 5:1, and 10:1. (H) Quantification of Cytotox Green fluorescence shown in (G). (I) Quantification of Raji cell viability in co-culture based on luciferase activity. n = 2 biological replicates. Data are shown as mean ± SD. Scale bar = 100 μm.

    Article Snippet: To assess cytotoxic activity, CAR T cells were then co-cultured with CD20-expressing, luciferase-labeled Raji cells (ATCC, cat# CCL-86-LUC2) at effector-to-target ratios of 1:1, 2:1, 5:1, and 10:1.

    Techniques: Expressing, Activity Assay, Fluorescence, Co-Culture Assay, Luciferase